Physician profile
Sumit Mukherjee
NPI 1154647568
$263,870.36
in general payments reported to CMS, 2019-2025
47 companies · $45K in 2025
The $45K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,256 · 2020: $408 · 2021: $3,195 · 2022: $52K · 2023: $113K · 2024: $49K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $186K · Food and Beverage: $9,881 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Travel and Lodging: $3,701 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $186,066.99 |
| Food and Beverage | $9,881.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Travel and Lodging | $3,700.79 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $253,720.62 | 2021-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Pinnacle Biologics, INC | $2,797.38 | 2020-2025 | Photofrin |
| Astrazeneca Pharmaceuticals Lp | $1,655.96 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Grifols USA, LLC | $521.36 | 2019-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $460.94 | 2019-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Amgen INC. | $411.23 | 2019-2025 | Tezspire, Tavneos |
| Glaxosmithkline, LLC. | $376.45 | 2022-2025 | Nucala, Trelegy Ellipta |
| Harmony Biosciences LLC | $322.72 | 2023-2025 | Wakix |
| Mallinckrodt Hospital Products INC. | $307.60 | 2023-2025 | Acthar |
| Veran Medical Technologies, INC. | $264.64 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $262.11 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $259.87 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Genzyme Corporation | $215.17 | 2022-2025 | |
| Electromed, INC. | $180.77 | 2023-2025 | Smartvest |
| Verona Pharma, INC. | $175.34 | 2025 | Ohtuvayre |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $155.33 | 2022-2024 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Regeneron Healthcare Solutions, INC. | $125.86 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $120.45 | 2023-2025 | |
| Mylan Specialty L.P. | $116.58 | 2019-2024 | Yupelri |
| Galvanize Therapeutics, INC | $114.17 | 2024 | Aliya System |
| Insmed, INC. | $106.33 | 2024-2025 | Brinsupri, Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $100.61 | 2019 | |
| Merck Sharp & Dohme LLC | $100.48 | 2024-2025 | Winrevair, Keytruda, Verquvo |
| Janssen Pharmaceuticals, INC | $94.74 | 2019 | |
| Paratek Pharmaceuticals, INC. | $73.25 | 2024-2025 | Nuzyra |
| United Therapeutics Corporation | $71.53 | 2019-2024 | Orenitram, Tyvaso |
| Axsome Therapeutics, INC. | $69.66 | 2025 | Sunosi |
| Viatris Specialty LLC | $61.17 | 2025 | Yupelri |
| Baxter Healthcare | $60.78 | 2022-2024 | Hillrom - Monarch Airway Clearance System |
| Sunovion Pharmaceuticals INC. | $53.65 | 2019 | |
| Olympus America INC. | $45.56 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $43.99 | 2022 | |
| Siemens Medical Solutions USA, INC. | $43.48 | 2024 | Cios Spin |
| Caris Mpi, INC. | $38.96 | 2025 | Mi Cancer Seek |
| Gilead Sciences, INC. | $38.69 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $36.60 | 2024-2025 | Lumryz |
| Astellas Pharma US INC | $34.14 | 2024 | Cresemba |
| Covidien Lp | $32.14 | 2020 | |
| Pfizer INC. | $27.76 | 2019-2022 | |
| 3b Medical, INC. | $27.46 | 2025 | Luna |
| Amarin Pharma, INC. | $26.81 | 2019 | |
| Genentech USA, INC. | $24.47 | 2024 | Alecensa, Tecentriq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.36 | 2020 | |
| Abbvie INC. | $22.38 | 2025 | |
| Philips North America LLC | $18.19 | 2023 | |
| Aegerion Pharmaceuticals, INC. | $16.27 | 2019 | |
| Shire North American Group INC | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Mukherjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.